CRF ANTAGONISTS AND HETEROBICYCLIC COMPOUNDS
CRF antagonists comprising as an active ingredient, the compound of formula (I) wherein A ring is 5-6 membered mono-cyclic ring which may be substituted; B ring is 5-7 membered unsaturated mono-heterocyclic ring which may be contained another 1-2 of hetero atom(s) and substituted by another substitu...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KATSUMATA, SEISHI KISHI, AKIHIRO SAITO, TETSUJI OBITSU, TETSUO MINAMOTO, CHIAKI NAKAI, HISAO KATAYAMA, HIDEO YOSHIDA, MAYUKI |
| description | CRF antagonists comprising as an active ingredient, the compound of formula (I)
wherein A ring is 5-6 membered mono-cyclic ring which may be substituted; B ring is 5-7 membered unsaturated mono-heterocyclic ring which may be contained another 1-2 of hetero atom(s) and substituted by another substituents; W 1 and W 2 is carbon atom or nitrogen atom; Z is NR 3 , oxygen atom, sulfur which may be oxidized or CR 4 R 5 ; R' is alkyl, alkenyl or alkynyl that may be substituted, amino which may be protected, hydroxyl which may be protected, S(O) n R 6 , COR 7 , or cyclic group which may be substituted; R 2 is unsaturated cyclic group which may be substituted. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1666468A4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1666468A4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1666468A43</originalsourceid><addsrcrecordid>eNrjZNBxDnJTcPQLcXT39_MMDgkGsl0UPFxDXIP8nTydI519PJ0VnP19A_xD_VyCeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAoZmZmYmZhaOJMRFKAF5QJQU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRF ANTAGONISTS AND HETEROBICYCLIC COMPOUNDS</title><source>esp@cenet</source><creator>KATSUMATA, SEISHI ; KISHI, AKIHIRO ; SAITO, TETSUJI ; OBITSU, TETSUO ; MINAMOTO, CHIAKI ; NAKAI, HISAO ; KATAYAMA, HIDEO ; YOSHIDA, MAYUKI</creator><creatorcontrib>KATSUMATA, SEISHI ; KISHI, AKIHIRO ; SAITO, TETSUJI ; OBITSU, TETSUO ; MINAMOTO, CHIAKI ; NAKAI, HISAO ; KATAYAMA, HIDEO ; YOSHIDA, MAYUKI</creatorcontrib><description>CRF antagonists comprising as an active ingredient, the compound of formula (I)
wherein A ring is 5-6 membered mono-cyclic ring which may be substituted; B ring is 5-7 membered unsaturated mono-heterocyclic ring which may be contained another 1-2 of hetero atom(s) and substituted by another substituents; W 1 and W 2 is carbon atom or nitrogen atom; Z is NR 3 , oxygen atom, sulfur which may be oxidized or CR 4 R 5 ; R' is alkyl, alkenyl or alkynyl that may be substituted, amino which may be protected, hydroxyl which may be protected, S(O) n R 6 , COR 7 , or cyclic group which may be substituted; R 2 is unsaturated cyclic group which may be substituted.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070321&DB=EPODOC&CC=EP&NR=1666468A4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070321&DB=EPODOC&CC=EP&NR=1666468A4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KATSUMATA, SEISHI</creatorcontrib><creatorcontrib>KISHI, AKIHIRO</creatorcontrib><creatorcontrib>SAITO, TETSUJI</creatorcontrib><creatorcontrib>OBITSU, TETSUO</creatorcontrib><creatorcontrib>MINAMOTO, CHIAKI</creatorcontrib><creatorcontrib>NAKAI, HISAO</creatorcontrib><creatorcontrib>KATAYAMA, HIDEO</creatorcontrib><creatorcontrib>YOSHIDA, MAYUKI</creatorcontrib><title>CRF ANTAGONISTS AND HETEROBICYCLIC COMPOUNDS</title><description>CRF antagonists comprising as an active ingredient, the compound of formula (I)
wherein A ring is 5-6 membered mono-cyclic ring which may be substituted; B ring is 5-7 membered unsaturated mono-heterocyclic ring which may be contained another 1-2 of hetero atom(s) and substituted by another substituents; W 1 and W 2 is carbon atom or nitrogen atom; Z is NR 3 , oxygen atom, sulfur which may be oxidized or CR 4 R 5 ; R' is alkyl, alkenyl or alkynyl that may be substituted, amino which may be protected, hydroxyl which may be protected, S(O) n R 6 , COR 7 , or cyclic group which may be substituted; R 2 is unsaturated cyclic group which may be substituted.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBxDnJTcPQLcXT39_MMDgkGsl0UPFxDXIP8nTydI519PJ0VnP19A_xD_VyCeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAoZmZmYmZhaOJMRFKAF5QJQU</recordid><startdate>20070321</startdate><enddate>20070321</enddate><creator>KATSUMATA, SEISHI</creator><creator>KISHI, AKIHIRO</creator><creator>SAITO, TETSUJI</creator><creator>OBITSU, TETSUO</creator><creator>MINAMOTO, CHIAKI</creator><creator>NAKAI, HISAO</creator><creator>KATAYAMA, HIDEO</creator><creator>YOSHIDA, MAYUKI</creator><scope>EVB</scope></search><sort><creationdate>20070321</creationdate><title>CRF ANTAGONISTS AND HETEROBICYCLIC COMPOUNDS</title><author>KATSUMATA, SEISHI ; KISHI, AKIHIRO ; SAITO, TETSUJI ; OBITSU, TETSUO ; MINAMOTO, CHIAKI ; NAKAI, HISAO ; KATAYAMA, HIDEO ; YOSHIDA, MAYUKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1666468A43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KATSUMATA, SEISHI</creatorcontrib><creatorcontrib>KISHI, AKIHIRO</creatorcontrib><creatorcontrib>SAITO, TETSUJI</creatorcontrib><creatorcontrib>OBITSU, TETSUO</creatorcontrib><creatorcontrib>MINAMOTO, CHIAKI</creatorcontrib><creatorcontrib>NAKAI, HISAO</creatorcontrib><creatorcontrib>KATAYAMA, HIDEO</creatorcontrib><creatorcontrib>YOSHIDA, MAYUKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KATSUMATA, SEISHI</au><au>KISHI, AKIHIRO</au><au>SAITO, TETSUJI</au><au>OBITSU, TETSUO</au><au>MINAMOTO, CHIAKI</au><au>NAKAI, HISAO</au><au>KATAYAMA, HIDEO</au><au>YOSHIDA, MAYUKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRF ANTAGONISTS AND HETEROBICYCLIC COMPOUNDS</title><date>2007-03-21</date><risdate>2007</risdate><abstract>CRF antagonists comprising as an active ingredient, the compound of formula (I)
wherein A ring is 5-6 membered mono-cyclic ring which may be substituted; B ring is 5-7 membered unsaturated mono-heterocyclic ring which may be contained another 1-2 of hetero atom(s) and substituted by another substituents; W 1 and W 2 is carbon atom or nitrogen atom; Z is NR 3 , oxygen atom, sulfur which may be oxidized or CR 4 R 5 ; R' is alkyl, alkenyl or alkynyl that may be substituted, amino which may be protected, hydroxyl which may be protected, S(O) n R 6 , COR 7 , or cyclic group which may be substituted; R 2 is unsaturated cyclic group which may be substituted.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP1666468A4 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CRF ANTAGONISTS AND HETEROBICYCLIC COMPOUNDS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T08%3A54%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KATSUMATA,%20SEISHI&rft.date=2007-03-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1666468A4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |